CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 18,784 shares at $21.72 ($408K) on 2016-12-30, disclosed to the SEC on 2017-01-04.
Open-market purchase of $408k RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.72 | 512 | $11K | 2.7% |
| 2 | $21.72 | 1,730 | $38K | 9.2% |
| 3 | $21.72 | 480 | $10K | 2.6% |
| 4 | $21.72 | 2,510 | $55K | 13.4% |
| 5 | $21.72 | 1,130 | $25K | 6.0% |
| 6 | $21.72 | 2,810 |
| $61K |
| 15.0% |
| 7 | $21.72 | 220 | $5K | 1.2% |
| 8 | $21.72 | 2,810 | $61K | 15.0% |
| 9 | $21.72 | 220 | $5K | 1.2% |
| 10 | $21.72 | 480 | $10K | 2.6% |
| 11 | $21.72 | 512 | $11K | 2.7% |
| 12 | $21.72 | 1,130 | $25K | 6.0% |
| 13 | $21.72 | 1,730 | $38K | 9.2% |
| 14 | $21.72 | 2,510 | $55K | 13.4% |
| Total | $21.72 avg | 18,784 | $408K | 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |